Lantheus Holdings, Inc.
General ticker "LNTH" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $4.7B (TTM average)
Lantheus Holdings, Inc. follows the US Stock Market performance with the rate: 21.7%.
Estimated limits based on current volatility of 2.2%: low 96.67$, high 101.00$
Factors to consider:
- Total employees count: 808 (-3.1%) as of 2024
- Top business risk factors: Product quality issues, Product defects, Acquisition/divestiture risks, Geopolitical risks, Cybersecurity threats
- Current price 31.0% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [44.02$, 76.55$]
- 2026-12-31 to 2027-12-31 estimated range: [41.91$, 72.96$]
Financial Metrics affecting the LNTH estimates:
- Negative: with PPE of 11.0 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 20.16 > 18.39
- Positive: 6.59 < Operating cash flow per share per price, % of 8.69
- Positive: Return on assets ratio (scaled to [-100,100]) of 9.49 > 6.06
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: -14.17 < Investing cash flow per share per price, % of -13.97
- Positive: 42.59 < Shareholder equity ratio, % of 48.93 <= 64.29
- Negative: Industry inventory ratio change (median), % of 0.87 > 0.28
- Negative: negative Industry operating income (median)
Short-term LNTH quotes
Long-term LNTH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,296.43MM | $1,542.33MM | $1,541.61MM |
| Operating Expenses | $931.79MM | $1,085.35MM | $1,230.78MM |
| Operating Income | $364.64MM | $456.98MM | $310.83MM |
| Non-Operating Income | $46.30MM | $-26.00MM | $2.96MM |
| Interest Expense | $20.02MM | $19.67MM | $19.75MM |
| R&D Expense | $77.71MM | $168.10MM | $177.31MM |
| Income(Loss) | $410.94MM | $430.98MM | $313.79MM |
| Taxes | $84.28MM | $118.53MM | $80.23MM |
| Net Income(Loss)* | $326.66MM | $312.44MM | $233.56MM |
| Stockholders Equity | $815.89MM | $1,088.01MM | $1,089.80MM |
| Inventory | $64.03MM | $68.03MM | $64.67MM |
| Assets | $1,651.15MM | $1,980.34MM | $2,227.40MM |
| Operating Cash Flow | $305.26MM | $544.75MM | $390.14MM |
| Capital expenditure | $46.55MM | $51.62MM | $36.09MM |
| Investing Cash Flow | $5.94MM | $-226.01MM | $-627.17MM |
| Financing Cash Flow | $-13.06MM | $-118.54MM | $-316.58MM |
| Earnings Per Share** | $4.79 | $4.52 | $3.46 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.